Home›Stock Screener›Sanofi Consumer Healthcare›Financial Statements

Sanofi Consumer Healthcare Complete Financial Statements

3 Years of Data
2025 - 2023

In FYNone, Sanofi Consumer Healthcare (SANOFICONR) reported revenue ₹969 Cr, net profit ₹266 Cr and EPS ₹115.50, with a net profit margin of 26.8% and ROE of 62.5%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Compare with SANOFICONR fair price to assess whether the stock is under or overvalued.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 26.76% 2025 data
EBITDA Margin 36.45% 2025 data
Operating Margin 35.00% 2025 data
Return on Assets 43.88% 2025 data
Return on Equity 62.50% 2025 data

Balance Sheet Ratios

Current Ratio 14.11 2025 data
Equity Ratio 70.20% 2025 data
Asset Turnover 1.64 2025 data

SANOFICONR Revenue, Net Profit & EBITDA — Year-on-Year Growth

SANOFICONR YoY (March 2025 vs Period) — revenue +8.0%, net profit +10.8%, EBITDA +13.8%, expenses +4.9%. For live price, earnings ratios and company overview, see SANOFICONR screener.

Revenue Growth
+8.0%
Year-over-Year
Net Profit Growth
+10.8%
Year-over-Year
EBITDA Growth
+13.8%
Year-over-Year
Expense Growth
+4.9%
Year-over-Year
Assets Growth
+26.9%
Year-over-Year
Equity Growth
+40.7%
Year-over-Year
Operating Cash Flow Growth
-60.1%
Year-over-Year
Investing Cash Flow Growth
+300.0%
Year-over-Year
Financing Cash Flow Growth
-16.4%
Year-over-Year

SANOFICONR Income Statement — Revenue, EBITDA & Net Profit

Sanofi Consumer Healthcare revenue ₹969 Cr, EBITDA ₹372 Cr, net profit ₹266 Cr, EPS ₹115.50 (None) — net profit margin 26.8%.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023
Revenue 969 897 738 560
Expenses 597 569 454 337
EBITDA 372 327 284 223
Operating Profit Margin % 37.00% 35.00% 37.00% 39.00%
Depreciation 13 12 5 2
Interest 2 2 4 0
Profit Before Tax 357 320 247 219
Tax 94 80 66 54
Net Profit 266 240 181 165
Earnings Per Share (₹) 115.50 104.27 78.59 71.60

SANOFICONR Balance Sheet — Assets, Liabilities & Shareholders' Equity

SANOFICONR total assets ₹547 Cr, total equity ₹384 Cr, total liabilities ₹ Cr (2025) — ROE 62.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 547 431 345
Current Assets 494 392 335
Fixed Assets 36 29 5
Capital Work in Progress 0 1 3
Investments 0 0 0
Other Assets 511 402 338
LIABILITIES
Total Liabilities
Current Liabilities 35 28 8
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 384 273 208
Share Capital 23 23 2
Reserves & Surplus 361 250 183

SANOFICONR Cash Flow Statement — Operating, Investing & Financing

Sanofi Consumer Healthcare operating cash flow ₹175 Cr, investing ₹8 Cr, financing ₹-135 Cr, net cash flow ₹48 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 175 439 0
Investing Activities 8 2 0
Financing Activities -135 -116 2
Net Cash Flow 48 325 2